Changes in platelet GPIbα and ADAM17 during the acute stage of atherosclerotic ischemic stroke among Chinese

Abstract

Glycoprotein (GP) Ibα ectodomain shedding has important implications for thrombosis and hemostasis. A disintegrin and metalloproteinase 17 (ADAM17) was identified to play an essential role in agonist induced GPIbα shedding. The relationship of GPIbα shedding and ADAM17 in the acute stage of atherosclerotic ischemic stroke (AIS) patients has not been thoroughly studied. A total of 306 patients and 230 controls matched for age, sex, race, history of hypertension and diabetes mellitus were enrolled in the study. GPIbα, ADAM17, glycocalicin were detected by flow cytometry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) respectively. Compared with the control group, the expression of GPIbα in patients with acute ischemic stroke was significantly lower (P=0.000, P<0.01). Plasma glycocalicin and ADAM17 in AIS group were higher than those in control group (P=0.699, P=0.000). Pearson’s analysis showed glycocalicin bore no correlation with GPIbα in AIS patients (r=0.095, P>0.05). GPIbα and National Institute of Health Stroke Scale (NIHSS) had negative correlation (r=−0.514, P<0.01). Our findings indicate that ADAM17 may be a risk factor for ischemic stroke in Chinese and the expression of GPIbα can serve as a measure for stroke severity.

Keywords

GPIbα / stroke / ADAM17 / glycocalicin / platelets

References

[1] LopezAD, MathersCD, EzzatiM, et al.. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 2006, 367(9524): 1747-1757

[2] FeiginVL, LawesCM, BennetDA, et al.. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol, 2003, 2(1): 43-53

[3] StollG, KleinschnitzC, NieswandtB. The role of glycoprotein Ibalpha and von Willebrand factor interaction in stroke development. Hamostaseologie, 2010, 30(3): 136-138

[4] BergmeierW, PiffathCL, ChengG, et al.. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res, 2004, 95(7): 677-683

[5] WhiteMM, JenningsLK. Platelet protocols. Research and Clinical Laboratory Procedures, 1999, San Diego, Academic Press

[6] ZhangY, ZhaoY, LuS, et al.. A high-throughput biotinavidin-elisa for studying expression of platelet membrane glycoproteins and its clinical application. Tohoku J Exp Med, 2010, 222(1): 83-88

[7] del ZoppoGJ. The role of platelets in ischemic stroke. Neurology, 1998, 51(3Suppl3): S9-S14

[8] TokuueJ, HayashiJ, HataY, et al.. Enhanced platelet aggregability under high shear stress after treadmill exercise in patients with effort angina. Thromb Haemost, 1996, 75(5): 833-837

[9] SonodaA, MurataM, ItoD, et al.. Association between platelet glycoprotein Ib genotype and ischemic cerebrovascular disease. Stroke, 2000, 31(2): 493-497

[10] MaguireJM, ThakkinstianA, SturmJ, et al.. Polymorphisms in platelet glycoprotein 1balpha and factor VII and risk of ischemic stroke: a meta-analysis. Stroke, 2008, 39(6): 1710-1716

[11] ElversM, StegnerD, HagedornI, et al.. Impaired αIIbβ3 integrin activation and shear-dependent thrombus formation in mice lacking phospolipase D1. Sci Signal, 2010, 3(103): ra1

[12] HanY, WangZ, ZhuM, et al.. Study of platelet membrane glycoproteins and its fibrinogen binding reaction in patients with cerebral infarction and diabetes mellitus. Zhonghua Xueyexue Zazhi (Chinese), 2000, 21(3): 129-131

[13] AlanD. Flow cytometry: a clinical test of platelet function. J Blood, 1996, 87(12): 4925-4936

[14] DaiK, YanR, LiS, et al.. Prolonged inhibition of protein kinase A results in metalloproteinase-dependent platelet GPIba shedding. Thromb Res, 2009, 124(1): 101-109

[15] BrillA, ChauhanAK, CanaultM, et al.. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res, 2009, 84(1): 137-144

[16] AktasB, PozgajovaM, BergmeierW, et al.. Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem, 2005, 280(48): 39716-39722

[17] StollG, KleinschnitzC, NieswandtB. Combating innate inflammation: a new paradigm for acute treatment of stroke?. Ann NY Acad Sci, 2010, 1207: 149-154

[18] BoilardE, NigrovicPA, LarabeeK, et al.. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science, 2010, 327(5965): 580-583

[19] BeerJH, BuchiL, SteinerB. Glycocalicin: a new assay-the normal plasma levels and its potential usefulness in selected diseases. Blood, 1994, 83(3): 691-702

[20] CollerBS, KalomirisE, SteinbergM, et al.. Evidence that glycocalicin circulates in normal plasma. J Clin Invest, 1984, 73(3): 794-799

[21] WangX, FeuersteinGZ, XuL, et al.. Inhibition of tumor necrosis factor-nlpha. converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol Pharmacol, 2004, 65(4): 890-896

[22] HurtadoO, LizasoainI, Fernández-ToméP, et al.. TACE/ADAM17-TNFα pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate. J Cereb Blood Flow Metab, 2002, 22(5): 576-585

[23] CárdenasA, MoroMA, LezaJC, et al.. Up-regulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J Cere Blood Flow Metab, 2002, 22(11): 1297-1302